Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15581948rdf:typepubmed:Citationlld:pubmed
pubmed-article:15581948lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15581948lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:15581948lifeskim:mentionsumls-concept:C0042149lld:lifeskim
pubmed-article:15581948lifeskim:mentionsumls-concept:C0205312lld:lifeskim
pubmed-article:15581948lifeskim:mentionsumls-concept:C1559154lld:lifeskim
pubmed-article:15581948lifeskim:mentionsumls-concept:C0814225lld:lifeskim
pubmed-article:15581948lifeskim:mentionsumls-concept:C0440743lld:lifeskim
pubmed-article:15581948lifeskim:mentionsumls-concept:C1514162lld:lifeskim
pubmed-article:15581948lifeskim:mentionsumls-concept:C1522673lld:lifeskim
pubmed-article:15581948pubmed:issue3lld:pubmed
pubmed-article:15581948pubmed:dateCreated2004-12-7lld:pubmed
pubmed-article:15581948pubmed:abstractTextThe coexistence of minimal uterine disease and extrauterine metastases is common in patients with uterine papillary serous carcinoma (UPSC). Only complete surgical staging accurately depicts the extent of this disease. The purpose of this study was to evaluate different therapeutic options in surgically staged patients.lld:pubmed
pubmed-article:15581948pubmed:languageenglld:pubmed
pubmed-article:15581948pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15581948pubmed:citationSubsetIMlld:pubmed
pubmed-article:15581948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15581948pubmed:statusMEDLINElld:pubmed
pubmed-article:15581948pubmed:monthDeclld:pubmed
pubmed-article:15581948pubmed:issn0090-8258lld:pubmed
pubmed-article:15581948pubmed:authorpubmed-author:SchwartzP EPElld:pubmed
pubmed-article:15581948pubmed:authorpubmed-author:KellyM GMGlld:pubmed
pubmed-article:15581948pubmed:authorpubmed-author:McAlpineJJlld:pubmed
pubmed-article:15581948pubmed:authorpubmed-author:HugVVlld:pubmed
pubmed-article:15581948pubmed:authorpubmed-author:ChambersS KSKlld:pubmed
pubmed-article:15581948pubmed:authorpubmed-author:RutherfordT...lld:pubmed
pubmed-article:15581948pubmed:authorpubmed-author:O'MalleyDDlld:pubmed
pubmed-article:15581948pubmed:authorpubmed-author:AzodiMMlld:pubmed
pubmed-article:15581948pubmed:authorpubmed-author:DziuraJJlld:pubmed
pubmed-article:15581948pubmed:issnTypePrintlld:pubmed
pubmed-article:15581948pubmed:volume95lld:pubmed
pubmed-article:15581948pubmed:ownerNLMlld:pubmed
pubmed-article:15581948pubmed:authorsCompleteYlld:pubmed
pubmed-article:15581948pubmed:pagination469-73lld:pubmed
pubmed-article:15581948pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:meshHeadingpubmed-meshheading:15581948...lld:pubmed
pubmed-article:15581948pubmed:year2004lld:pubmed
pubmed-article:15581948pubmed:articleTitlePatients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.lld:pubmed
pubmed-article:15581948pubmed:affiliationDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Yale University School of Medicine, 333 Cedar Street, PO Box 2080-63, New Haven, CT 06520-8063, USA. mgkelly74@aol.comlld:pubmed
pubmed-article:15581948pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15581948pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed